A Study to Evaluate the Safety, Tolerability, and Immunogenicity of UB-612 COVID-19 Vaccine
Clinical trial NCT04545749 · COMPLETED
Trial details
- NCT number
- NCT04545749
- Sponsor
- United Biomedical Inc., Asia
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-25
- Primary completion
- 2021-01-18
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.